You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,718,426

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,718,426

Title:	Preparation method of a hair dermal papilla cell preparation, composition and method for regenerating hair follicles, and animal having regenerated hair follicles
Abstract:	The present invention provides a method for preparing a hair dermal papilla cell preparation comprising preparing a cell suspension by removing epidermal tissue from skin tissue and subjecting the resulting dermal tissue fraction to collagenase treatment, and cyropreserving the cell suspension to kill the follicular epidermal cells. The present invention also provides a composition for regenerating hair follicles comprising hair dermal papilla cell and epidermal cells, wherein the ratio of the number of hair dermal papilla cell to the number of epidermal cells is from 1:10 to 10:1.
Inventor(s):	Kishimoto; Jiro (Yokohama, JP), Ehama; Ritsuko (Yokohama, JP), Ideta; Ritsuro (Yokohama, JP), Arai; Takayuki (Yokohama, JP), Yano; Kiichiro (Yokohama, JP), Soma; Tsutomu (Yokohama, JP)
Assignee:	Shiseido Company, Ltd. (Tokyo, JP)
Application Number:	10/574,697
Patent Claims:	1. A composition comprising a hair dermal papilla cell preparation and epidermal cells, wherein the hair dermal cell preparation is prepared by a method comprising: (a) providing a skin tissue; (b) removing epidermal tissue from the skin tissue, thereby producing a dermal tissue fraction; (c) subjecting the dermal tissue fraction to collagenase treatment, thereby producing a cell suspension comprising hair dermal papilla cells; and (d) cryopreserving the cell suspension to kill follicular epidermal cells present in the cell suspension, thereby producing the hair dermal papilla cell preparation; wherein the composition is prepared by mixing the hair dermal papilla cell preparation with an amount of active epidermal cells to obtain a ratio of the number of hair dermal papilla cells to the number of active epidermal cells from 1:10 to 10:1, thereby producing the composition; and wherein the hair dermal papilla cells and the active epidermal cells are each obtained from a mammal selected from the group consisting of a mouse, a rat, and a human. 2. A composition according to claim 1, wherein the ratio of the number of hair dermal papilla cells to the number of epidermal cells is from 1:3 to 10:1. 3. A composition according to claim 1, wherein cryopreserving the cell suspension is carried out after adjusting the cell density of the cell suspension to 1.times.10.sup.5 to 1.times.10.sup.8 cells/ml. 4. A composition according to claim 1, wherein cryopreserving the cell suspension is carried out at a temperature of -80.degree. C. or lower. 5. A composition according to claim 1, wherein cryopreserving the cell suspension is carried out in liquid nitrogen. 6. A composition according to claim 1, wherein cryopreserving the cell suspension is carried out for a period of 1 week or more. 7. The composition of claim 1, wherein the hair dermal papilla cells and the active epidermal cells both originate in mice, both originate in rats or both originate in humans. 8. The composition of claim 1, wherein the mammal for obtaining the hair dermal papilla cells and the mammal for obtaining the active epidermal cells are the same mammal, are different mammals of the same species, or are different species of mammals. 9. The composition of claim 1, wherein the active epidermal cells are obtained from human foreskin.

Details for Patent 7,718,426

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2023-10-06
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.